OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia
Yongwei Su, Jenna L. Carter, Xinyu Li, et al.
Cancer Research (2024) Vol. 84, Iss. 7, pp. 1084-1100
Closed Access | Times Cited: 8
Yongwei Su, Jenna L. Carter, Xinyu Li, et al.
Cancer Research (2024) Vol. 84, Iss. 7, pp. 1084-1100
Closed Access | Times Cited: 8
Showing 8 citing articles:
Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia
Emeline Boët, Jean‐Emmanuel Sarry
Cancer Research (2024) Vol. 84, Iss. 7, pp. 950-952
Closed Access | Times Cited: 7
Emeline Boët, Jean‐Emmanuel Sarry
Cancer Research (2024) Vol. 84, Iss. 7, pp. 950-952
Closed Access | Times Cited: 7
ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress
Jenna L. Carter, Yongwei Su, Eman T. Al‐Antary, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Jenna L. Carter, Yongwei Su, Eman T. Al‐Antary, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia
Dorian Forte, Roberto Maria Pellegrino, Paolo Falvo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Dorian Forte, Roberto Maria Pellegrino, Paolo Falvo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Mitohormesis : la clé de voûte de la résistance thérapeutique des cellules cancéreuses
Emeline Boët, Estelle Saland, Sarah Skuli, et al.
Comptes Rendus Biologies (2024) Vol. 347, Iss. G1, pp. 59-75
Open Access
Emeline Boët, Estelle Saland, Sarah Skuli, et al.
Comptes Rendus Biologies (2024) Vol. 347, Iss. G1, pp. 59-75
Open Access
Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia
Patryk Firmanty, Monika Chomczyk, Shubhankar Dash, et al.
Current Pharmacology Reports (2024)
Open Access
Patryk Firmanty, Monika Chomczyk, Shubhankar Dash, et al.
Current Pharmacology Reports (2024)
Open Access
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
Amal Kamal Abdel‐Aziz
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access
Amal Kamal Abdel‐Aziz
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access
CircPSD3 Aggravates Tumor Progression by Maintaining TCA Cycle and Mitochondrial Function via Regulating SUCLG2 in Thyroid Carcinoma
Shubin Hong, Yijia Sun, Beinan Han, et al.
Research Square (Research Square) (2024)
Closed Access
Shubin Hong, Yijia Sun, Beinan Han, et al.
Research Square (Research Square) (2024)
Closed Access
Development of Novel Imipridones with Alkyne- and Triazole-Linked Warheads on the Tricyclic Skeleton, Showing Superior Ability to Eradicate PANC-1 and Fadu Cells Compared to ONC201
Tamás Czuczi, József Murányi, István Móra, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13176-13176
Open Access
Tamás Czuczi, József Murányi, István Móra, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13176-13176
Open Access
